DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease

Abstract

Mitochondrial dysfunction and ensuing oxidative damage is typically thought to be a primary cause of Huntington's disease, Alzheimer's disease, and Parkinson disease. There is little doubt that mitochondria (MT) become defective as neurons die, yet whether MT defects are the primary cause or a detrimental consequence of toxicity remains unanswered. Oxygen consumption rate (OCR) and glycolysis provide sensitive and informative measures of the functional status MT and the cells metabolic regulation, yet these measures differ depending on the sample source; species, tissue type, age at measurement, and whether MT are measured in purified form or in a cell. The effects of these various parameters are difficult to quantify and not fully understood, but clearly have an impact on interpreting the bioenergetics of MT or their failure in disease states. A major goal of the review is to discuss issues and coalesce detailed information into a reference table to help in assessing mitochondrial dysfunction as a cause or consequence of Huntington's disease.

Authors:
ORCiD logo [1];  [1]
  1. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Biophysics and Integrated Bioimaging Division
Publication Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
National Institutes of Health (NIH)
OSTI Identifier:
1393099
Grant/Contract Number:  
AC02-05CH11231; NS060115; CA092584
Resource Type:
Accepted Manuscript
Journal Name:
Mechanisms of Ageing and Development
Additional Journal Information:
Journal Volume: 161; Journal Issue: Part A; Journal ID: ISSN 0047-6374
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Polyzos, Aris A., and McMurray, Cynthia T. The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease. United States: N. p., 2016. Web. doi:10.1016/j.mad.2016.09.003.
Polyzos, Aris A., & McMurray, Cynthia T. The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease. United States. https://doi.org/10.1016/j.mad.2016.09.003
Polyzos, Aris A., and McMurray, Cynthia T. Mon . "The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease". United States. https://doi.org/10.1016/j.mad.2016.09.003. https://www.osti.gov/servlets/purl/1393099.
@article{osti_1393099,
title = {The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease},
author = {Polyzos, Aris A. and McMurray, Cynthia T.},
abstractNote = {Mitochondrial dysfunction and ensuing oxidative damage is typically thought to be a primary cause of Huntington's disease, Alzheimer's disease, and Parkinson disease. There is little doubt that mitochondria (MT) become defective as neurons die, yet whether MT defects are the primary cause or a detrimental consequence of toxicity remains unanswered. Oxygen consumption rate (OCR) and glycolysis provide sensitive and informative measures of the functional status MT and the cells metabolic regulation, yet these measures differ depending on the sample source; species, tissue type, age at measurement, and whether MT are measured in purified form or in a cell. The effects of these various parameters are difficult to quantify and not fully understood, but clearly have an impact on interpreting the bioenergetics of MT or their failure in disease states. A major goal of the review is to discuss issues and coalesce detailed information into a reference table to help in assessing mitochondrial dysfunction as a cause or consequence of Huntington's disease.},
doi = {10.1016/j.mad.2016.09.003},
journal = {Mechanisms of Ageing and Development},
number = Part A,
volume = 161,
place = {United States},
year = {Mon Sep 12 00:00:00 EDT 2016},
month = {Mon Sep 12 00:00:00 EDT 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 19 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Astrocyte Regulation of Synaptic Behavior
journal, October 2014


Coenzyme Q10 serum levels in Huntington’s disease
book, January 2004


Complex I Defect in muscle from patients with Huntington's disease: Complex I Defect in HD
journal, March 1998

  • Arenas, Joaquín; Campos, Yolanda; Ribacoba, René
  • Annals of Neurology, Vol. 43, Issue 3
  • DOI: 10.1002/ana.410430321

Mitochondrial Biology and Neurological Diseases
journal, February 2016


Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis
journal, September 2013


Involvement of Mitochondrial Complex II Defects in Neuronal Death Produced by N-Terminus Fragment of Mutated Huntingtin
journal, April 2006

  • Benchoua, Alexandra; Trioulier, Yaël; Zala, Diana
  • Molecular Biology of the Cell, Vol. 17, Issue 4
  • DOI: 10.1091/mbc.E05-07-0607

Mutant huntingtin and mitochondrial dysfunction
journal, December 2008

  • Bossy-Wetzel, Ella; Petrilli, Alejandra; Knott, Andrew B.
  • Trends in Neurosciences, Vol. 31, Issue 12
  • DOI: 10.1016/j.tins.2008.09.004

Impaired Brain Energy Metabolism in the BACHD Mouse Model of Huntington's Disease: Critical Role of Astrocyte–Neuron Interactions
journal, June 2014

  • Boussicault, Lydie; Hérard, Anne-Sophie; Calingasan, Noel
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 34, Issue 9
  • DOI: 10.1038/jcbfm.2014.110

Partial Inhibition of Brain Succinate Dehydrogenase by 3-Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in Rat
journal, February 1998


Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse
journal, July 2008

  • Brown, T. B.; Bogush, A. I.; Ehrlich, M. E.
  • Human Molecular Genetics, Vol. 17, Issue 20
  • DOI: 10.1093/hmg/ddn206

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
journal, May 1997

  • Browne, Susan E.; Bowling, Allen C.; Macgarvey, Usha
  • Annals of Neurology, Vol. 41, Issue 5
  • DOI: 10.1002/ana.410410514

Increased Susceptibility of Striatal Mitochondria to Calcium-Induced Permeability Transition
journal, June 2003


Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s Disease
journal, August 2015


HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation
journal, August 2015


The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
journal, June 2015

  • Carvalho, Cristina; Correia, Sónia C.; Cardoso, Susana
  • Expert Review of Neurotherapeutics, Vol. 15, Issue 8
  • DOI: 10.1586/14737175.2015.1058160

Prospects for neuroprotective therapies in prodromal Huntington's disease: Neuroprotective Therapies In Prodromal HD
journal, February 2014

  • Chandra, Abhishek; Johri, Ashu; Beal, M. Flint
  • Movement Disorders, Vol. 29, Issue 3
  • DOI: 10.1002/mds.25835

Mitochondrial Diseases of the Brain
journal, October 2013


A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin
journal, May 2013

  • Damiano, Maria; Diguet, Elsa; Malgorn, Carole
  • Human Molecular Genetics, Vol. 22, Issue 19
  • DOI: 10.1093/hmg/ddt242

Mitochondria in Huntington's disease
journal, January 2010

  • Damiano, Maria; Galvan, Laurie; Déglon, Nicole
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1802, Issue 1
  • DOI: 10.1016/j.bbadis.2009.07.012

Energy Thresholds in Brain Mitochondria
journal, May 1998

  • Davey, Gavin P.; Peuchen, Stefan; Clark, John B.
  • Journal of Biological Chemistry, Vol. 273, Issue 21
  • DOI: 10.1074/jbc.273.21.12753

Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases?
journal, September 2015

  • de Groot, Natalia Sánchez; Burgas, Marc Torrent
  • Cellular and Molecular Life Sciences, Vol. 72, Issue 24
  • DOI: 10.1007/s00018-015-2038-4

Mitochondria, calcium-dependent neuronal death and neurodegenerative disease
journal, May 2012


Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington’s disease: Interactions between neurons and astrocytes
journal, July 2012


Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates
journal, March 2007

  • Fukui, Hirokazu; Moraes, Carlos T.
  • Human Molecular Genetics, Vol. 16, Issue 7
  • DOI: 10.1093/hmg/ddm023

Impaired Regulation of Brain Mitochondria by Extramitochondrial Ca2+ in Transgenic Huntington Disease Rats
journal, November 2008

  • Gellerich, Frank N.; Gizatullina, Zemfira; Nguyen, Huu P.
  • Journal of Biological Chemistry, Vol. 283, Issue 45
  • DOI: 10.1074/jbc.M709555200

Low stability of huntington muscle Mitochondria against Ca 2+ in R6/2 mice
journal, January 2006

  • Gizatullina, Zemfira Z.; Lindenberg, Katrin S.; Harjes, Phoebe
  • Annals of Neurology, Vol. 59, Issue 2
  • DOI: 10.1002/ana.20754

Juvenile Huntington chorea: Clinical, ultrastructural, and biochemical studies
journal, January 1978


The metabolic profile of early Huntington's disease- a combined human and transgenic mouse study
journal, April 2008


Early Deficits in Glycolysis Are Specific to Striatal Neurons from a Rat Model of Huntington Disease
journal, November 2013


Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease
journal, October 2015


Mitochondrial defect in Huntington's disease caudate nucleus
journal, March 1996


Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease
journal, January 2007

  • Gu, Xiaofeng; André, Véronique M.; Cepeda, Carlos
  • Molecular Neurodegeneration, Vol. 2, Issue 1
  • DOI: 10.1186/1750-1326-2-8

Regional Specificity of Brain Atrophy in Huntington's Disease
journal, December 1998

  • Halliday, G. M.; McRitchie, D. A.; Macdonald, V.
  • Experimental Neurology, Vol. 154, Issue 2
  • DOI: 10.1006/exnr.1998.6919

Oxidative metabolism in YAC128 mouse model of Huntington's disease
journal, June 2015

  • Hamilton, James; Pellman, Jessica J.; Brustovetsky, Tatiana
  • Human Molecular Genetics, Vol. 24, Issue 17
  • DOI: 10.1093/hmg/ddv209

The hunt for huntingtin function: interaction partners tell many different stories
journal, August 2003


Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease
journal, February 2012

  • Hickey, Miriam A.; Zhu, Chunni; Medvedeva, Vera
  • Molecular and Cellular Neuroscience, Vol. 49, Issue 2
  • DOI: 10.1016/j.mcn.2011.10.007

Xpa deficiency reduces CAG trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1
journal, September 2011

  • Hubert, Leroy; Lin, Yunfu; Dion, Vincent
  • Human Molecular Genetics, Vol. 20, Issue 24
  • DOI: 10.1093/hmg/ddr421

Impaired GAPDH ‐induced mitophagy contributes to the pathology of Huntington's disease
journal, August 2015

  • Hwang, Sunhee; Disatnik, Marie‐Hélène; Mochly‐Rosen, Daria
  • EMBO Molecular Medicine, Vol. 7, Issue 10
  • DOI: 10.15252/emmm.201505256

Antioxidants in Huntington's disease
journal, May 2012

  • Johri, Ashu; Beal, M. Flint
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1822, Issue 5
  • DOI: 10.1016/j.bbadis.2011.11.014

Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis
journal, November 2003


OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells
journal, April 2007

  • Kovtun, Irina V.; Liu, Yuan; Bjoras, Magnar
  • Nature, Vol. 447, Issue 7143
  • DOI: 10.1038/nature05778

Cortical and Subcortical Glucose Consumption Measured by pet in Patients with Huntington'S Disease
journal, January 1990


The role of mitochondrial dysfunction in age-related diseases
journal, November 2015

  • Lane, Rebecca K.; Hilsabeck, Tyler; Rea, Shane L.
  • Biochimica et Biophysica Acta (BBA) - Bioenergetics, Vol. 1847, Issue 11
  • DOI: 10.1016/j.bbabio.2015.05.021

Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
journal, February 2008

  • Lim, Dmitry; Fedrizzi, Laura; Tartari, Marzia
  • Journal of Biological Chemistry, Vol. 283, Issue 9
  • DOI: 10.1074/jbc.M704704200

Neurological abnormalities in a knock-in mouse model of Huntington's disease
journal, January 2001


Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation
journal, February 1997

  • Mangiarini, Laura; Sathasivam, Kirupa; Mahal, Amarbirpal
  • Nature Genetics, Vol. 15, Issue 2
  • DOI: 10.1038/ng0297-197

Metabolic control analysis and threshold effect in oxidative phosphorylation: Implications for mitochondrial pathologies
journal, January 1997

  • Letellier, T.; Bédes, F.; Malgat, M.
  • Molecular and Cellular Biochemistry, Vol. 174, Issue 1/2, p. 143-148
  • DOI: 10.1023/A:1006875517267

Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease
journal, February 1987

  • Mazziotta, John C.; Phelps, Michael E.; Pahl, Jorg J.
  • New England Journal of Medicine, Vol. 316, Issue 7
  • DOI: 10.1056/NEJM198702123160701

Mechanisms of trinucleotide repeat instability during human development
journal, October 2010

  • McMurray, Cynthia T.
  • Nature Reviews Genetics, Vol. 11, Issue 11
  • DOI: 10.1038/nrg2828

Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin
journal, September 2005

  • Milakovic, Tamara; Johnson, Gail V. W.
  • Journal of Biological Chemistry, Vol. 280, Issue 35
  • DOI: 10.1074/jbc.M504749200

Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells
journal, November 2006

  • Milakovic, Tamara; Quintanilla, Rodrigo A.; Johnson, Gail V. W.
  • Journal of Biological Chemistry, Vol. 281, Issue 46
  • DOI: 10.1074/jbc.M603845200

Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice
journal, August 2012

  • Mollersen, L.; Rowe, A. D.; Illuzzi, J. L.
  • Human Molecular Genetics, Vol. 21, Issue 22
  • DOI: 10.1093/hmg/dds337

Factors Associated With Slow Progression in Huntington's Disease
journal, August 1991


Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington's disease
journal, November 2012

  • Napoli, Eleonora; Wong, Sarah; Hung, Connie
  • Human Molecular Genetics, Vol. 22, Issue 5
  • DOI: 10.1093/hmg/dds503

Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease
journal, September 2016


Comparing the effects of mitochondrial targeted and localized antioxidants with cellular antioxidants in human skin cells exposed to UVA and hydrogen peroxide
journal, October 2013

  • Oyewole, Anne O.; Wilmot, Marie‐Claire; Fowler, Mark
  • The FASEB Journal, Vol. 28, Issue 1
  • DOI: 10.1096/fj.13-237008

Current status of PET imaging in Huntington’s disease
journal, February 2016

  • Pagano, Gennaro; Niccolini, Flavia; Politis, Marios
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Issue 6
  • DOI: 10.1007/s00259-016-3324-6

Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease
journal, May 1996


Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
journal, July 2002

  • Panov, Alexander V.; Gutekunst, Claire-Anne; Leavitt, Blair R.
  • Nature Neuroscience, Vol. 5, Issue 8
  • DOI: 10.1038/nn884

Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease
journal, August 1990


Astrocytes: a central element in neurological diseases
journal, December 2015


Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes
journal, February 2016

  • Polyzos, Aris; Holt, Amy; Brown, Christopher
  • Human Molecular Genetics, Vol. 25, Issue 9
  • DOI: 10.1093/hmg/ddw051

Platelet Mitochondrial Complex I and I+III Activities Do Not Correlate with Cerebral Mitochondrial Oxidative Metabolism
journal, October 2010

  • Powers, William J.; Haas, Richard H.; Le, Thuy
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 31, Issue 1
  • DOI: 10.1038/jcbfm.2010.179

Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease
journal, January 2013

  • Quintanilla, Rodrigo A.; Jin, Youngnam N.; von Bernhardi, Rommy
  • Molecular Neurodegeneration, Vol. 8, Issue 1
  • DOI: 10.1186/1750-1326-8-45

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
journal, October 1998

  • Reddy, P. Hemachandra; Williams, Maya; Charles, Vinod
  • Nature Genetics, Vol. 20, Issue 2
  • DOI: 10.1038/2510

Differential loss of striatal projection neurons in Huntington disease.
journal, August 1988

  • Reiner, A.; Albin, R. L.; Anderson, K. D.
  • Proceedings of the National Academy of Sciences, Vol. 85, Issue 15
  • DOI: 10.1073/pnas.85.15.5733

Conditional targeting of medium spiny neurons in the striatal matrix
journal, March 2015

  • Reinius, Björn; Blunder, Martina; Brett, Frances M.
  • Frontiers in Behavioral Neuroscience, Vol. 9
  • DOI: 10.3389/fnbeh.2015.00071

Mitochondrial control of cell bioenergetics in Parkinson’s disease
journal, November 2016


Threshold Effect and Tissue Specificity
journal, November 1999

  • Rossignol, Rodrigue; Malgat, Monique; Mazat, Jean-Pierre
  • Journal of Biological Chemistry, Vol. 274, Issue 47
  • DOI: 10.1074/jbc.274.47.33426

Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
journal, May 2004


HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
journal, August 2005

  • Seong, Ihn Sik; Ivanova, Elena; Lee, Jong-Min
  • Human Molecular Genetics, Vol. 14, Issue 19
  • DOI: 10.1093/hmg/ddi319

Therapeutic advances in Huntington's Disease: Therapeutic Advances in HD
journal, July 2015

  • Shannon, Kathleen M.; Fraint, Avram
  • Movement Disorders, Vol. 30, Issue 11
  • DOI: 10.1002/mds.26331

Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease
journal, October 2012


Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
journal, June 2006

  • Smith, Karen M.; Matson, Samantha; Matson, Wayne R.
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1762, Issue 6
  • DOI: 10.1016/j.bbadis.2006.03.004

Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity
journal, February 2011

  • Song, Wenjun; Chen, Jin; Petrilli, Alejandra
  • Nature Medicine, Vol. 17, Issue 3
  • DOI: 10.1038/nm.2313

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
journal, January 1983

  • Sorbi, Sandro; Bird, Edward D.; Blass, John P.
  • Annals of Neurology, Vol. 13, Issue 1
  • DOI: 10.1002/ana.410130116

Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation
journal, February 2006

  • Squitieri, Ferdinando; Cannella, Milena; Sgarbi, Gianluca
  • Mechanisms of Ageing and Development, Vol. 127, Issue 2
  • DOI: 10.1016/j.mad.2005.09.010

Abnormal morphology of peripheral cell tissues from patients with Huntington disease
journal, October 2009

  • Squitieri, Ferdinando; Falleni, Alessandra; Cannella, Milena
  • Journal of Neural Transmission, Vol. 117, Issue 1
  • DOI: 10.1007/s00702-009-0328-4

Biochemical abnormalities in Huntington's chorea brains
journal, September 1974


Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset
journal, May 2009

  • Swami, Meera; Hendricks, Audrey E.; Gillis, Tammy
  • Human Molecular Genetics, Vol. 18, Issue 16
  • DOI: 10.1093/hmg/ddp242

Biochemical abnormalities and excitotoxicity in Huntington's disease brain
journal, January 1999


Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
journal, January 2000


Complex I Is Rate-limiting for Oxygen Consumption in the Nerve Terminal
journal, April 2009

  • Telford, Jayne E.; Kilbride, Seán M.; Davey, Gavin P.
  • Journal of Biological Chemistry, Vol. 284, Issue 14
  • DOI: 10.1074/jbc.M809101200

Studies on Brain Biopsies of Patients with HuntingtonʼS Chorea
journal, January 1974

  • Tellez-Nagel, Isabel; Johnson, Anne B.; Terry, Robert D.
  • Journal of Neuropathology and Experimental Neurology, Vol. 33, Issue 2
  • DOI: 10.1097/00005072-197404000-00008

Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
journal, November 2000


Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro
journal, September 2004


Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo
journal, December 2006

  • Trushina, Eugenia; Singh, Raman Deep; Dyer, Roy B.
  • Human Molecular Genetics, Vol. 15, Issue 24
  • DOI: 10.1093/hmg/ddl434

Clinical correlates of mitochondrial function in Huntington's disease muscle
journal, January 2007

  • Turner, Christopher; Cooper, J. Mark; Schapira, Anthony H. V.
  • Movement Disorders, Vol. 22, Issue 12
  • DOI: 10.1002/mds.21540

Repeat instability during DNA repair: Insights from model systems
journal, January 2015

  • Usdin, Karen; House, Nealia C. M.; Freudenreich, Catherine H.
  • Critical Reviews in Biochemistry and Molecular Biology, Vol. 50, Issue 2
  • DOI: 10.3109/10409238.2014.999192

Transgenic rat model of Huntington's disease
journal, March 2003

  • von Horsten, S.; Schmitt, I.; Nguyen, H. P.
  • Human Molecular Genetics, Vol. 12, Issue 6
  • DOI: 10.1093/hmg/ddg075

Huntington Disease
journal, January 1998


Neuropathological Classification of Huntingtonʼs Disease
journal, January 1985

  • Vonsattel, Jean-Paul; Myers, Richard H.; Stevens, Thomas J.
  • Journal of Neuropathology and Experimental Neurology, Vol. 44, Issue 6
  • DOI: 10.1097/00005072-198511000-00003

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
journal, November 2006


Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse
journal, January 1999


Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells
journal, April 2012

  • Xun, Zhiyin; Lee, Do-Yup; Lim, James
  • Mechanisms of Ageing and Development, Vol. 133, Issue 4
  • DOI: 10.1016/j.mad.2012.01.008

Inhibition of mitochondrial protein import by mutant huntingtin
journal, May 2014

  • Yano, Hiroko; Baranov, Sergei V.; Baranova, Oxana V.
  • Nature Neuroscience, Vol. 17, Issue 6
  • DOI: 10.1038/nn.3721

A Novel BACHD Transgenic Rat Exhibits Characteristic Neuropathological Features of Huntington Disease
journal, October 2012


Works referencing / citing this record:

Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases
journal, December 2017

  • Connolly, Niamh M. C.; Theurey, Pierre; Adam-Vizi, Vera
  • Cell Death & Differentiation, Vol. 25, Issue 3
  • DOI: 10.1038/s41418-017-0020-4

Bioenergetic deficits in Huntington’s disease iPSC-derived neural cells and rescue with glycolytic metabolites
journal, March 2019

  • Kedaigle, Amanda J.; Fraenkel, Ernest; Atwal, Ranjit S.
  • Human Molecular Genetics, Vol. 29, Issue 11
  • DOI: 10.1093/hmg/ddy430

Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models
journal, May 2017

  • Buck, Eva; Bayer, Hanna; Lindenberg, Katrin S.
  • Frontiers in Molecular Neuroscience, Vol. 10
  • DOI: 10.3389/fnmol.2017.00156

Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.
text, January 2018

  • Connolly, Niamh MC; Theurey, Pierre; Adam-Vizi, Vera
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.24241

Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases
journal, December 2017

  • Connolly, Niamh M. C.; Theurey, Pierre; Adam-Vizi, Vera
  • Cell Death & Differentiation, Vol. 25, Issue 3
  • DOI: 10.1038/s41418-017-0020-4